Source: Annual Congress 2003 - COPD: risk factors and course of disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Duelien, P. S. Bakke, W. M. Vollmer, S. A. Buist, A. Gulsvik (Bergen, Norway; Portland, United States Of America). Change in transfer factor for carbon monoxide. Predictors in a community cohort study. Eur Respir J 2003; 22: Suppl. 45, 2234

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in COPD using the transfer factor for carbon monoxide Z-score Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Five-year follow-up of smoking attitudes in a secondary school evaluated by questionnaires and carbon monoxide (CO) measurements Source: Eur Respir J 2002; 20: Suppl. 38, 137s Year: 2002 Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study Source: Eur Respir J, 59 (1) 2003639; 10.1183/13993003.03639-2020 Year: 2022 Efficacy of assessing carbon monoxide in a smoking cessation programme for patients with pulmonary disorders Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002 Effect of the presence of lung cancer on diffusion capacity of carbon monoxide in a cohort of smokers Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Exhaled carbon monoxide in asthma: a prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003 Factors affecting exhaled carbon monoxide measurement as a biomarker of smoking Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010 Assessment of the patient Source: Eur Respir Mon; 2008: 42: 44–50 Year: 2008 Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Smoking status in patiets with COPD and Asthma: A comparison of self-reported behavior with exhaled carbon monoxide Source: Eur Respir J 2002; 20: Suppl. 38, 577s Year: 2002 The respiratory health effects of nitrogen dioxide in children with asthma Source: Eur Respir J 2011; 38: 303-309 Year: 2011 Etiology of severe reduction of single-breath carbon monoxide diffusion coefficient. Study of 195 cases Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Predictors for longitudinal change in DLCO in a community based sample Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Factors affecting carbon monoxide diffusion capacity in early convalescence phase of severe COVID19 patients Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function Year: 2021 Optimal cut-off point of exhaled carbon monoxide to validate self-reported smoking status in healthy adults Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation? Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 Effects of adopting the Global Lung Function Initiative 2017 reference equations on the interpretation of carbon monoxide transfer factor Source: Eur Respir J, 55 (5) 1901905; 10.1183/13993003.01905-2019 Year: 2020 Exhaled carbon monoxide and degree of dependency in smokers attending an antismoking center Source: Annual Congress 2007 - Smoking cessation Year: 2007 Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006 Effect of corrected Global Lung Function Initiative reference equations on carbon monoxide transfer factor interpretation Source: Eur Respir J, 57 (6) 2004459; 10.1183/13993003.04459-2020 Year: 2021